Aletho News

Trust me – I’m from Big Pharma

By Kate Dunlop | The Conservative Woman | June 29, 2021

THE behaviour of political and public-health leaders across the world over the past fifteen months has been deplorable: for reasons yet to be confirmed, they have turned themselves into procurers for Big Pharma.

Governments not only funded fast-paced vaccine development but also psychologically prepared their populations to receive them by means of sustained media manipulation. Billions of pounds in public money has been transferred to drug corporations which have been insulated from civil legal challenge in respect of harm or loss arising from their products.

Medical staff have lost a great deal of public trust by colluding with vaccine stakeholders and withdrawing general support. They have delivered experimental gene therapies to people who did not need them but who were cowed into having them, and they have exposed young people, healthy adults and pregnant women to unnecessary risks without their full knowledge or consent in breach of their own ethical and professional standards.

When the UK government granted Pfizer civil legal immunity in December 2020 it enabled a private commercial entity to avoid the already restricted product liabilities that might have given it cause to consider. Regulation 345 of the Human Medicines Regulations (HMR) 2012, gave it blanket protection from civil lawsuits arising from any ‘unforeseen complications’ with Covid jabs.

Such legal immunity is unusual but came from an emergency government consultation in September 2020, after the Department of Health and Social Care under Matt Hancock had determined that changes to civil liability were necessary to ‘better facilitate the widespread use of a Covid-19 vaccine in Britain’.

Emergency approval had already been granted for Pfizer/BioNTech’s two-shot ‘vaccines’ through Regulation 174 of the HMR, which allowed them to avoid statutory licensing procedures, so with civil legal protections, they were unfettered. Crony capitalism and avarice beat prudence and public protection.

The government, likely for political expediency,  included Covid jabs on the Vaccine Damage Payments Scheme (VDPS) (Vaccine Damage Payments (Specified Disease) Order 2020, SI 2020/1411). This scheme is taxpayer funded and provides for ‘the very rare possibility where someone is severely disabled as a result of taking a vaccine’.

To qualify for assistance, a claimant must provide medical evidence that proves to the Department of Work and Pensions that on ‘the balance of probability’ there is a ‘causal link between the vaccine and the claimed disability [and] that the resulting disability is severe – up to 60 per cent’.

Those who can prove their cause receive a one-off tax-free payment of £120,000. The test poses two key challenges for claimants, the high threshold of disablement and the relatively low level of compensation.

Consumer Protection Rights and common law rights still apply for people damaged by Covid-19 vaccines but due to the legal definition of product defects and a rule known as the ‘state-of-the-art defence’, it may be very difficult to get compensation: only time and case law will tell.

The very fact that Covid vaccine research was funded by government is curious and may, arguably, make them also liable; that manufacturers’ experimental products were given emergency authorisation is questionable; that immunity against civil action for damages was granted is an egregious betrayal; and the continuing promotion of the jabs, despite growing evidence of harm, is evil.

In both the UK and the US, a condition for the release of any new drug is that there be no other effective treatments available. We all know now that proven therapeutics were available to treat the early symptoms of Covid-19 but that they were, and still are, suppressed. Viable alternatives include ivermectin,  hydroxychloroquine and zinc, dexamethasone and other corticosteroids (prednisone, methylprednisolone), and remdesivir.

What distinguishes these remedies from novel ‘vaccines’ is that they are already fully licensed and off-patent. They are relatively cheap to manufacture and administer, and therefore unlikely to bring new long-term income streams to Big Pharma.

All of which brings us unhappily to our question: Why on earth was our government so eager to fund the activity of international drug giants and why did it provide them with tax-funded legal immunities for products that only they will profit from?

It’s not as if Boris Johnson, Matt Hancock or their Sage advisers can claim ignorance of the business practices or track records of these outfits: they all have strong public links to them, either as employees, researchers, directors, business partners, shareholders, or recipients of funding.

In December 2020, Global Justice Now, a UK-based ‘social justice organisation’ published a report which concluded:

‘The current pharmaceutical model is . . . deeply flawed, delivering outcomes which are poor value for money for the public sector, which exacerbate global inequality and which are driven by the objective to make sky-high returns to shareholders, not a healthier population.’

It described the market as dysfunctional with incentives for ‘the most appalling behaviour including aggressive marketing of inappropriate drugs, kickbacks to doctors, claims of testing drugs on children without proper consent, massive price hikes on essential medicines, profiteering, blocking competition, and secrecy’.

In the US, Public Citizen, a non-profit, consumer rights advocacy group, published Twenty Seven Years of Pharmaceutical Industry Criminal and Civil Penalties 1991 through 2017, which detailed the 412 settlements against drug companies that resulted in them paying out $38.6 billion in criminal and civil penalties. A small loss relative to the $711 billion in net profits made by the 11 largest global drug companies during ten of those 27 years (2003-2012).

Pfizer, now the leading Covid mRNA vaccine manufacturer, was found guilty of more transgressions than any other company and forced to pay 34 settlements amounting to $4.7billion: AstraZeneca had to settle just over $1billion on 13 matters, including concealing data.

Johnson & Johnson was ordered to pay $2.8billion in 20 settlements that included unlawful promotion of prescription drugs and unfair practices.

Such penalties are clearly accepted by the companies as a ‘cost of doing business’. They are certainly no incentive to changing behaviour.

Criminal prosecutions of executives of drug companies are extremely rare, as are prosecutions of politicians. Nonetheless, a forensic assessment of who is liable for the risks, damages, and losses brought by Covid -19 ‘vaccines’ is long overdue.

June 30, 2021 - Posted by aletho | Corruption, Timeless or most popular | UK